Although not extensively studied or approved in PPL with #T1D over the last 15-year period, GLP-1RA prescriptions significantly increased across all BMI categories in a dose-response manner among both youth and adults with T1D #obesity https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16300
Comments